CClinicalTrials.gg
CompletedNCT02873871Updated Aug 12, 2020

Comparison of 2 Hemostasis Techniques After Transradial Coronary

An interventional study of Standardized compressive dressing and Hemostasis with TerumoBand® in Coronary Artery Disease With Myocardial Infarction, sponsored by Hospital de Clinicas de Porto Alegre. Completed at 1 site in Brazil. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2020-08-12.

Sponsored by Hospital de Clinicas de Porto Alegre · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Aug 2015, registered Apr 2016).
Phase
Not applicable
Study type
Interventional
Enrollment
600
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Randomized clinical trial to compare radial artery patency after transradial coronary catheterization using 2 different hemostasis techniques. Patients submitted to diagnostic or therapeutic coronary catheterization will be prospectively enrolled in this single-center trial and will be randomized to radial hemostasis with TerumoBand® or a standardized compressive dressing with gauze and elastic bandage.

Read the detailed description

Randomized clinical trial to compare radial artery patency after transradial coronary catheterization using 2 different hemostasis techniques. Patients submitted to diagnostic or therapeutic coronary catheterization will be prospectively enrolled in this single-center trial and will be randomized to radial hemostasis with TerumoBand® or a standardized compressive dressing with gauze and elastic bandage.

Interventions: Radial hemostasis with TerumoBand® and Radial hemostasis with a standardized compressive dressing

02

Conditions studied

  • Coronary Artery Disease With Myocardial Infarction
03

In context

Coronary Artery Disease

5,598 studies on the registry are indexed under Coronary Artery Disease; 957 are open to participants now.

This study's enrollment of 600 is above the median of 124 across 3,436 interventional studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

Hospital de Clinicas de Porto Alegre is the lead sponsor of 450 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult patients submitted to elective or urgent coronary catheterization who presented with a A, B or C curve on oximetry test before the procedure

Exclusion criteria

Exclusion Criteria:

  • Inability to understand the study and sign the informed consent form
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
600 participants (actual)

Study arms

  • Other
    Control group

    Standardized compressive dressing

    Device: Standardized compressive dressing

  • Experimental
    Intervention group

    Hemostasis with TerumoBand®

    Device: Hemostasis with TerumoBand®

Interventions

  • DeviceStandardized compressive dressing

    Standardized compressive dressing

  • DeviceHemostasis with TerumoBand®

    Hemostasis with TerumoBand®

06

What researchers measure

Primary outcomes

  1. Radial artery occlusion evaluated using Barbeau's test

    test immediately after hemostasis compression device withdrawal

    Time frame: up to 3 hours

Secondary outcomes

  1. Vascular complications

    Clinical assesment

    Time frame: up to 3 hours

  2. Radial access site pain

    standardized scale

    Time frame: up to 3 hours

07

Study locations

1 site
  • Universidade Federal do Rio Grande do Sul - Post Graduated Program
    Porto Alegre, Rio Grande Do Sul 90035003, Brazil
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 12, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02873871
Lead sponsor
Hospital de Clinicas de Porto Alegre
Responsible party
Sponsor
First posted
Aug 22, 2016
Start date
Aug 2015
Primary completion
Dec 2017
Completion
Dec 2017
Last update
Aug 12, 2020

Study contacts

Eneida Rejane Rabelo da Silva, RN, MSc, ScD
study chair · Hospital de Clinicas de Porto Alegre

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion